Outgoings expected to be around 5.8m next quarter, so I'd still expect incomings to be higher (considering costs should be down).. That means another profitable quarter ahead, despite any December slowdown.. The 2 quarters following that should be really good with Pegasus at full scale & new product lines coming online (with active sales), plus the possibility of finally getting a licensee for Alexiflam NF..
AJX Price at posting:
40.5¢ Sentiment: Hold Disclosure: Held
